Login

Interview with OMEGA CEO Raynald Aeschlimann explores the future of the brand, lessons learned, and more insights into their vision. 00:10:00

Share On Facebook Share On Twitter

Antonio Bastos, founder and CEO of Omega Energia

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Financial Wellness Month: Essential Tips for a Strong Financial Start in 2024 | Phil Ball, President , Bollin Wealth Management LLC.
00:10:00
Michael Vodicka analyzes Diodes, Inc. (DIOD) for its semiconductor prospects and Central Garden & Pet Company for its position in the consumer goods market.|Keh-Shew Lu. Chairman and Chief Executive Officer of Diodes, Inc
00:10:00
"Navigating the Evolving Energy Landscape: Insights from Goldman Sachs Leaders"
00:10:00
Reviewing the Electric Vehicle Market and Raw Material Demand Impact: Insights from Wolfgang Berghard, Roland Berger
00:10:00
James Hill Discusses Singular Health’s Vertically Integrated Medical Business | James Hill, COO , Singular Health Group Ltd.
00:10:00
Learn about the top trends and technologies in psychedelic therapeutics|Amy Kruse,General Partner,Prime Movers Lab
00:10:00
Thesis Gold and Benchmark Metals: A Transformative Merger for Precious Metals Development
00:10:00
Globant's CEO and Co-Founder, Martín Migoya, celebrates 20 years of leading innovation and success.
00:00:00
Oventus Medical out to transform the sleep-disordered breathing market with new tech - John Cox , CEO, Oventus Medical Ltd
00:10:00
Brickability Group PLC: Leading Construction Materials Distributor | Alan Simpson - CEO of Brickability Gr
00:10:00
Unlocking ArcMail's Speed: Next-Gen Interface Demo for Hosted Customers | Brett Jackson, CEO of cyren ltd
00:10:00
A Revolutionary Paradigm for Understanding Human Existence| Pier Vincenzo Piazza, CEO, Aelis Farma SA.

© 2017 - Neuhu+